Pneumococcal vaccination in developing countries. (Q53727040)

18 May 2018

http://europepmc.org/abstract/MED/16765742

title

Pneumococcal vaccination in developing countries. (English)

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

author

Kate O'Brien

2

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

David Goldblatt

8

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Maria Deloria Knoll

Maria Knoll

3

0 references

Brian Greenwood

10

Brian Greenwood

1 reference

18 May 2018

13

Shabir A Madhi

1 reference

18 May 2018

16

Mathuram Santosham

1 reference

18 May 2018

12

Keith P Klugman

1 reference

18 May 2018

19

Samba Sow

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Richard Adebayo Adegbola

4

Richard A Adegbola

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Ron Dagan

7

Ron Dagan

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Orin Levine

1

Orin S Levine

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

John Anthony Gerard Scott

18

J Anthony Scott

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Cynthia G Whitney

20

Cynthia G Whitney

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Hanna Nohynek

15

Hanna Nohynek

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Samir K Saha

17

Samir K Saha

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Thomas Cherian

6

Thomas Cherian

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Kim Mulholland

14

Kim Mulholland

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

author name string

Steven Black

5

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Adenike Grange

9

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Tom Hennessy

11

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

Felicity Cutts

21

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

language of work or name

English

0 references

publication date

1 June 2006

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

number of pages

3

1 reference

inferred from page(s)

published in

The Lancet

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

volume

367

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

issue

9526

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

page(s)

1880-1882

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

cites work

Estimates of world-wide distribution of child deaths from acute respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Bacteremia among children admitted to a rural hospital in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968703-5

7 January 2021

10.1016/S0140-6736(06)68703-5

Identifiers

DOI

1 reference

18 May 2018

http://europepmc.org/abstract/MED/16765742

1 reference

18 May 2018